Alpha Teknova, Inc. (TKNO): Free Cash Flow
-$9.79M
Year ended 2025-12-31
-$7.35M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.79M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$13.52M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$26.75M | n/m | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | -$55.55M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$28.95M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$2.96M | n/a | 2022-03-18, From 2020-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$9.79M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $1.22M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$395.87M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.04M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$25.37M | n/m |
| Neogen Corp (NEOG) | 2026-05-31 | $31.90M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$19.77M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$213.66M | n/m |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | -$83.00M | n/m |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗